LIX is building a futures market where institutions, investors and speculators can buy and sell life-expectancy risk—and create information for decisions far beyond trading.
LIX is being built as a place where pensions, insurers, reinsurers, banks, money managers, hedge funds, traders and other investors can bring different expectations, different risks and real capital into the same market. Some may want to reduce risk. Others may want to take it. Others may simply believe the market is wrong. Their trading can turn disagreement into price discovery—and create something the economy has never had at scale: a live, market-implied price for expectations about human life expectancy.
Human life. Financial consequence.
An annuity company promises income for life. A life insurer promises a payment when life ends. A pension can owe benefits for decades. A health insurer finances the future healthcare needs of a population. A reinsurer takes risks that other insurers do not want to keep. Governments finance healthcare and retirement systems at enormous scale.
All of them have to make decisions today about a future they cannot know exactly. They turn uncertainty into assumptions, and those assumptions become real business decisions.
Read the full economic storyHistorical experience, mortality data, medical information, claims, demographics and expert judgment are turned into models. Those models help determine what an insurer charges, what a pension owes, how a health plan budgets and how a retirement company plans for a lifetime.
They can affect product pricing, reserves, capital, treasury, investments, reinsurance, accounting, finance, audit, governance and regulatory conversations. In long-duration businesses, a view about human life expectancy can move from an actuarial model all the way to the balance sheet and the boardroom.
One insurer has a view. A pension has another. A reinsurer has another. Investors may have their own view about medicine, demographics or aging. Today those opinions do not continuously meet in one transparent market where capital can test them against each other.
LIX does not replace actuarial, medical or financial models. It adds a new source of information: a market price formed when institutions and investors with different expectations meet and trade.
Institutions estimate the future independently.
Risk holders, market makers and investors meet.
Trading makes expectations observable.
Trade, compare, plan, value, price and build.
A pandemic can change mortality quickly. A new class of medicines can change expectations about disease and long-term health. A breakthrough cancer therapy can alter how investors think about future survival. AI may accelerate parts of drug discovery and development. Today, institutions absorb developments like these through research, committees, experience studies, model updates and periodic assumption changes. LIX adds something different: a live market where institutions and investors can react as new information arrives, put capital behind competing views, and create a price that can begin moving before the next formal assumption cycle is complete.
COVID showed that a major health event can change mortality and observed life expectancy in a short period. A future pandemic or COVID-like event could force insurers, pensions, governments and investors to reassess assumptions rapidly.
As evidence, adoption and long-term outcomes around GLP-1 medicines evolve, investors can form different views about what those changes may ultimately mean for health and survival across populations.
A major therapy can change expectations for a disease long before decades of mortality history accumulate. Different investors will interpret the evidence differently—and at different speeds.
AI is increasingly being used across drug development. If it accelerates discovery, improves development or helps new therapies reach patients, the implications can eventually extend into health and survival expectations.
New information creates different views. Participants turn those views into bids and offers; trading makes a change in expectations observable.
A health shock, medical breakthrough, demographic shift or new evidence arrives.
Insurers, pensions, banks, money managers, hedge funds and other investors interpret it differently.
Participants can express those views through the LIX marketplace.
Trading can continuously update the market-implied view as information changes.
Institutions can compare, hedge, rebalance, reprice, plan and update decisions using a new market signal.
Historical data tells you what happened. A model tells you what you assume. A live market can show what participants are pricing now.
That difference can matter operationally. In a liquid LIX market, a major health event does not have to wait for an annual assumption review to become visible in price. Market participants can react throughout the trading day. Insurers, reinsurers and pensions can compare that repricing with their own models and decide whether to reprice products, adjust hedges, rebalance risk, revisit reinsurance, or change capital and investment decisions. The market does not replace their models; it gives those models a live external reference.
LIX begins with a real contract market: institutions and investors can buy, sell, hedge and take views on life-expectancy risk. Central clearing supports the market. Trading creates price discovery. Those prices can then become benchmarks, data, analytics, balance-sheet tools and the building blocks for new investment and retirement products.
The market comes first.Prices can become curves, benchmarks, market data, analytics and the foundation for new products.
The same market can have very different value depending on where you sit. An annuity writer may care about lifetime payments and risk transfer. A health insurer may care first about data and planning. A hedge fund may care about price discovery. A pharmaceutical company may care about how market expectations respond to medical innovation. Each industry gets its own journey.
RetirementHealthcareMedicineCapital marketsLifetime income depends on a view of human life expectancy.
Long-term promises begin with assumptions about mortality and survival.
Population health becomes premiums, claims, benefits and capital decisions.
A pension promise can continue for decades after retirement.
Medicare, Medicaid, ACA marketplaces and public retirement all plan around populations over time.
Drug economics sit between medicine, insurers, employers and patients.
A new market needs institutions that connect risk, capital and price.
A new market signal can become an investment input, benchmark and product building block.
Markets deepen when investors can disagree and put capital behind the disagreement.
Life-linked assets already depend on human outcomes; LIX can add a common market reference.
Medical innovation can change health outcomes—and the market may eventually show how expectations respond.
Reinsurance already exists to take risks that primary insurers do not want to keep.
Large employers finance health and retirement promises for entire workforces.
Every retirement plan contains an unanswered question: how long must the money last?
Hospitals plan care, capacity and capital around populations whose needs change over time.
That is how LIX can become more than an exchange. The marketplace can turn new information into prices; prices into benchmarks and data; and those signals into tools for risk, capital, pricing, planning, investment and product creation. The trade happens in the market. The information can flow back into the entire economy.